Pediatrics Information Center
Nirsevimab Under Review for Protection Against RSV for All Infants
Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
Your search for ACA returned 2891 results
Psychiatry Information Center
What the Buprenorphine X-Waiver Removal Means for Clinicians
AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.
Neurology Information Center
How Racial and Ethnic Disparities in Alzheimer Disease Affect Diagnosis, Quality of Care
Timothy S. Chang, MD, PhD and Lisa L. Barnes, PhD, discuss health disparities in Alzheimer disease and related dementias and how to improve clinical outcomes for patients from underrepresented groups.
Hospital Medicine Information Center
FDA Greenlights Ibuprofen Oral Suspension Compounding to Help With Hospital Supply
Increased demand for ibuprofen oral suspension products due to a surge in 3 circulating viruses prompted the Agency to issue compounding guidance.
Mood Disorder Information Center
Rykindo Approved for Schizophrenia, Bipolar Disorder
The approval was based on data from adequate and well-controlled studies with risperidone long-acting injection (intramuscular).
Psoriasis Information Center
Brodalumab Promising for the Treatment of Plaque Psoriasis in a Real-World Setting
The effectiveness and safety profile of brodalumab during a period of 104 weeks in everyday practice are reported.
ADHD Information Center
Women With ADHD at Increased Risk for Depression With Hormonal Contraceptive Use
Do women or girls with ADHD using hormonal contraceptives (HCs) have an increased risk for depression compared with HC users who do not have ADHD?
Psychiatry Information Center
Case Study: Ethics and Mental Illness in Pregnancy
A woman is evaluated by psychiatry on postpartum day 2 after staff noticed her talking to the mirror in her room and not showing affection to her newborn child. Case shows ethical decisions made when managing mental illness during pregnancy.
General Medicine
Top January 2023 FDA Approvals
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.
Practice Management Information Center
California Attorney General Sues Drugmakers Over Inflated Insulin Prices
California Attorney General Rob Bonta is taking 3 major drugmakers and 3 distributors to court, alleging the companies illegally raised prices at the expense of diabetes patients.
- Loading...
Loading...
Next post in Practice Management Information Center
Loading... 
Loading...